NASDAQ : TNON
Tenon Medical, Inc. — Financial statements
Healthcare · Medical Devices · United States
Last price 2.29 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 1.53M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Tenon Medical, Inc. (TNON) reported revenue of 5.31M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 5.31M | 3.94M | 3.28M | 2.93M | 691.00K | 160.00K |
| Cost of Revenue | 1.76M | 1.59M | 1.57M | 1.69M | 1.33M | 55.00K |
| Gross Profit | 3.55M | 2.36M | 1.71M | 1.24M | -641.00K | 105.00K |
| Selling, General & Admin | 13.28M | 12.22M | 12.87M | 13.80M | 14.68M | 4.85M |
| Research & Development | 2.38M | 2.15M | 2.60M | 3.16M | 2.83M | 1.72M |
| Operating Expenses | 15.66M | 14.37M | 15.48M | 16.97M | 17.51M | 6.57M |
| Operating Income | -12.11M | -12.01M | -13.77M | -15.73M | -18.15M | -6.46M |
| Interest Expense | -1.03M | -34.00K | -21.00K | -354.00K | -621.00K | |
| Interest & Investment Income | 136.00K | 236.00K | 183.00K | 167.00K | 180.00K | 2.00K |
| Other Non Operating Income (Expenses) | 87.00K | -56.00K | -18.00K | -1.00K | ||
| EBT Excluding Unusual Items | -12.92M | -11.78M | -13.67M | -15.58M | -18.34M | -7.08M |
| Merger & Restructuring Charges | -779.00K | -779.00K | ||||
| Legal Settlements | -574.00K | |||||
| Pretax Income | -13.70M | -12.56M | -13.67M | -15.58M | -18.92M | -7.08M |
| Earnings From Continuing Operations | -13.70M | -12.56M | -13.67M | -15.58M | -18.92M | -7.08M |
| Minority Interest in Earnings | 33.00K | |||||
| Net Income | -13.70M | -12.56M | -13.67M | -15.58M | -18.92M | -7.05M |
| Net Income to Common | -13.70M | -12.56M | -13.67M | -15.58M | -18.92M | -7.05M |
| Shares Outstanding (Basic) | 293.47K | 210.97K | 34.69K | |||
| Shares Outstanding (Diluted) | 293.47K | 210.97K | 34.69K | |||
| EPS (Basic) | -46.67 | -59.52 | -394.19 | |||
| EPS (Diluted) | -46.67 | -59.52 | -394.19 | |||
| Free Cash Flow | -12.82M | -11.77M | -10.06M | -12.54M | -12.87M | -4.39M |
| Free Cash Flow Per Share | -43.70 | -55.78 | -290.15 | |||
| Gross Margin | 66.81% | 59.79% | 52.21% | 42.38% | -92.76% | 65.62% |
| Operating Margin | -228.03% | -304.59% | -420.08% | -537.12% | -2,626.77% | -4,038.12% |
| Profit Margin | -257.85% | -318.36% | -417.24% | -532.14% | -2,737.63% | -4,405.00% |
| Free Cash Flow Margin | -241.43% | -298.38% | -307.11% | -428.42% | -1,862.81% | -2,746.25% |
| EBITDA | -11.80M | -11.76M | -13.36M | -15.53M | -18.07M | -6.46M |
| EBITDA Margin | -222.10% | -298.07% | ||||
| D&A For EBITDA | 315.00K | 257.00K | 408.00K | 199.00K | 78.00K | 2.00K |
| EBIT | -12.11M | -12.01M | -13.77M | -15.73M | -18.15M | -6.46M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 1.68M | 3.76M | 6.54M | 2.43M | 2.13M | 2.92M |
| Short-Term Investments | 6.44M | 4.40M | ||||
| Cash & Short-Term Investments | 1.68M | 3.76M | 6.54M | 2.43M | 8.57M | 7.32M |
| Receivables | 1.95M | 1.70M | 863.00K | 518.00K | 228.00K | 76.00K |
| Inventory | 783.00K | 1.05M | 606.00K | 554.00K | 415.00K | 188.00K |
| Prepaid Expenses | 400.00K | 260.00K | 206.00K | 389.00K | 134.00K | 87.00K |
| Total Current Assets | 4.81M | 6.77M | 8.21M | 3.89M | 9.35M | 7.67M |
| Property, Plant & Equipment | 2.20M | 1.05M | 1.15M | 1.61M | 1.67M | 1.19M |
| Goodwill | 2.41M | 2.41M | ||||
| Other Intangible Assets | 455.00K | 485.00K | ||||
| Long-Term Deferred Charges | 431.00K | 798.00K | 25.00K | 374.00K | ||
| Other Long-Term Assets | 51.00K | 51.00K | 51.00K | 51.00K | 51.00K | 41.00K |
| Total Assets | 9.92M | 10.76M | 9.84M | 6.34M | 11.09M | 9.27M |
| Accounts Payable | 628.00K | 845.00K | 369.00K | 433.00K | 550.00K | 478.00K |
| Accrued Expenses | 2.63M | 2.23M | 1.21M | 1.28M | 1.75M | 1.09M |
| Current Portion of Long-Term Debt | 1.17M | 13.51M | ||||
| Current Portion of Leases | 215.00K | 141.00K | 287.00K | 256.00K | 228.00K | 202.00K |
| Total Current Liabilities | 8.30M | 3.21M | 1.87M | 3.14M | 2.53M | 15.27M |
| Long-Term Leases | 1.13M | 141.00K | 428.00K | 683.00K | 911.00K | |
| Other Long-Term Liabilities | 2.23M | 2.51M | 1.86M | 2.00M | 1.62M | |
| Total Liabilities | 11.66M | 5.72M | 3.87M | 5.57M | 4.84M | 16.18M |
| Common Stock | 11.00K | 3.00K | 1.00K | |||
| Additional Paid-In Capital | 84.01M | 83.26M | 70.96M | 55.90M | 45.84M | 113.00K |
| Retained Earnings | -88.83M | -81.30M | -68.75M | -55.07M | -39.49M | -20.57M |
| Comprehensive Income & Other | -46.00K | -100.00K | -91.00K | |||
| Total Common Equity | -4.82M | 1.97M | 2.22M | 778.00K | 6.25M | -20.55M |
| Shareholders' Equity | -1.74M | 5.04M | 5.97M | 778.00K | 6.25M | -6.91M |
| Total Liabilities & Equity | 9.92M | 10.76M | 9.84M | 6.34M | 11.09M | 9.27M |
| Total Debt | 5.68M | 141.00K | 428.00K | 1.86M | 911.00K | 14.62M |
| Net Cash (Debt) | -4.00M | 3.62M | 6.11M | 571.00K | 7.66M | -7.30M |
| Net Cash Per Share | -13.63 | 17.14 | 176.07 | |||
| Filing Date Shares Outstanding | 667.05K | 322.75K | 159.57K | 89.60K | ||
| Total Common Shares Outstanding | 330.67K | 310.04K | 89.68K | 9.29M | ||
| Working Capital | -3.50M | 3.56M | 6.34M | 749.00K | 6.82M | -7.60M |
| Book Value Per Share | -14.57 | 6.34 | 24.74 | 0.08 | ||
| Tangible Book Value | -7.68M | -926.00K | 2.22M | 778.00K | 6.25M | -20.55M |
| Tangible Book Value Per Share | -23.22 | -2.99 | 24.74 | 0.08 | ||
| Machinery | 150.00K | 144.00K | 79.00K | 79.00K | 79.00K | 26.00K |
| Construction In Progress | 772.00K | 836.00K | 541.00K | 602.00K | 601.00K | |
| Leasehold Improvements | 15.00K | 15.00K | 15.00K | 15.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -13.70M | -12.56M | -13.67M | -15.58M | -18.92M | -7.05M |
| Depreciation & Amortization | 585.00K | 525.00K | 655.00K | 426.00K | 289.00K | 114.00K |
| Other Amortization | 1.03M | 5.00K | ||||
| Asset Writedown & Restructuring Costs | 77.00K | |||||
| Loss (Gain) From Sale of Investments | -16.00K | -2.00K | ||||
| Stock-Based Compensation | 1.15M | 1.69M | 3.85M | 4.14M | 4.46M | 1.60M |
| Provision & Write-off of Bad Debts | 22.00K | 16.00K | 41.00K | |||
| Other Operating Activities | -88.00K | 362.00K | 587.00K | |||
| Change in Accounts Receivable | -1.20M | -851.00K | -386.00K | -290.00K | -152.00K | -61.00K |
| Change in Inventory | 211.00K | -387.00K | -52.00K | -139.00K | -227.00K | -145.00K |
| Change in Accounts Payable | -256.00K | 486.00K | -64.00K | -117.00K | 72.00K | 444.00K |
| Change in Other Net Operating Assets | 478.00K | 326.00K | -244.00K | -627.00K | 2.03M | 214.00K |
| Operating Cash Flow | -11.77M | -10.74M | -9.88M | -12.18M | -12.03M | -4.29M |
| Capital Expenditures | -1.06M | -1.02M | -186.00K | -361.00K | -847.00K | -102.00K |
| Investment in Securities | 6.50M | -2.04M | -4.40M | |||
| Investing Cash Flow | -1.06M | -1.02M | -186.00K | 6.14M | -2.88M | -4.50M |
| Long-Term Debt Issued | 1.25M | 12.07M | ||||
| Long-Term Debt Repaid | -245.00K | |||||
| Net Debt Issued (Repaid) | 4.30M | 1.25M | 11.83M | |||
| Issuance of Common Stock | 6.86M | 7.42M | 5.56M | 14.14M | ||
| Other Financing Activities | 2.56M | 2.13M | 3.55M | -509.00K | -25.00K | -358.00K |
| Financing Cash Flow | 6.66M | 8.99M | 14.12M | 6.30M | 14.11M | 11.47M |
| Foreign Exchange Rate Adjustments | 46.00K | 38.00K | 7.00K | -2.00K | ||
| Net Cash Flow | -6.17M | -2.78M | 4.11M | 299.00K | -788.00K | 2.67M |
| Free Cash Flow | -12.82M | -11.77M | -10.06M | -12.54M | -12.87M | -4.39M |
| Free Cash Flow Margin | -241.43% | -298.38% | -307.11% | -428.42% | -1,862.81% | -2,746.25% |
| Free Cash Flow Per Share | -43.70 | -55.78 | -290.15 | |||
| Levered Free Cash Flow | -6.12M | -6.16M | -4.65M | -6.91M | -7.36M | -2.79M |
| Unlevered Free Cash Flow | -6.50M | -6.16M | -4.63M | -6.89M | -7.13M | -2.40M |
| Cash Interest Paid | 1.00K | |||||
| Cash Income Tax Paid | 1.00K | |||||
| Change in Working Capital | -766.00K | -426.00K | -746.00K | -1.17M | 1.72M | 452.00K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 1.37M | 10.57M | 5.90M | 3.90M | 17.75M | |
| Enterprise Value | 5.37M | 10.42M | 981.74K | 1.28M | 6.18M | |
| Last Close Price | 2.05 | 33.30 | 65.80 | 442.40 | 4,424.00 | |
| PS Ratio | 0.26 | 2.68 | 1.80 | 1.33 | 25.69 | |
| PB Ratio | 2.10 | 0.99 | 5.02 | 2.84 | ||
| P/TBV Ratio | 2.66 | 5.02 | 2.84 | |||
| EV/Sales Ratio | 1.01 | 2.64 | 0.30 | 0.44 | 8.95 | |
| Debt / Equity Ratio | -3.26 | 0.03 | 0.07 | 2.39 | 0.15 | -2.12 |
| Net Debt / Equity Ratio | -2.29 | -0.72 | -1.02 | -0.73 | -1.23 | -1.06 |
| Net Debt / EBITDA Ratio | -0.34 | 0.31 | 0.46 | 0.04 | 0.42 | -1.13 |
| Net Debt / FCF Ratio | -0.31 | 0.31 | 0.61 | 0.05 | 0.59 | -1.66 |
| Asset Turnover | 0.51 | 0.38 | 0.41 | 0.34 | 0.07 | 0.03 |
| Inventory Turnover | 2.40 | 1.91 | 2.70 | 3.48 | 4.42 | 0.48 |
| Quick Ratio | 0.44 | 1.70 | 3.96 | 0.94 | 3.48 | 0.48 |
| Current Ratio | 0.58 | 2.11 | 4.39 | 1.24 | 3.69 | 0.50 |
| Return on Equity (ROE) | -551.19% | -228.06% | -405.19% | -443.27% | ||
| Return on Assets (ROA) | -71.98% | -72.88% | -106.30% | -112.76% | -111.43% | -83.58% |
| Return on Capital Employed (ROCE) | -749.10% | -159.20% | -172.60% | -490.70% | -212.10% | 107.60% |
| Earnings Yield | -2,276.70% | -118.81% | -231.87% | -399.08% | -106.55% | |
| FCF Yield | -937.88% | -111.36% | -170.67% | -321.30% | -72.50% | |
| Buyback Yield / Dilution | -169.77% | -508.23% |